Biopol Chemicals SME
smeAlloted
GMP
₹4
smeAlloted
Biopol Chemicals SME
Track Live GMP, Subscription Status, and Allotment Updates for this IPO.
LIVE GMP
₹4
(+3.70%) Est. Gain
Investment Timeline
✓
IPO Open
6 Feb 2026
✓
IPO Close
10 Feb 2026
✓
Allotment
11 Feb 2026
✓
Listing
13 Feb 2026
🤖 Smart Analysis
Educational
*AI score is algorithmic and for educational purposes only.
Algorithm Verdict
NEUTRAL
48.5/100
🎯 Application Strategy
Action: ⚠️ NEUTRAL - Mixed signals, proceed with caution
Lots: Single lot only for diversification
⏳ Timing Advice
📊 Monitor subscription trends before applying
Key Factor Analysis
🚀
Demand
⭐ Strong subscription demand showing healthy investor interest
💰
Valuation
⚠️ Moderate valuation - fairly priced but limited upside
📈
Listing
⚠️ Limited listing gains expected (0-5%)
📊
Financials
⚠️ Average financials - growth could be better
Issue Details
🏷️Price Band
₹102.0 - ₹108.0
📦Lot Size
1200 shares
💰Issue Size
₹29.63 Cr
🛒Retail Quota
N/A
Frequently Asked Questions
What is the current GMP of Biopol Chemicals SME?
As of today, the Grey Market Premium (GMP) for Biopol Chemicals SME is ₹4, which is approximately (+3.70%) of the issue price. Please note that GMP is unofficial market intelligence and subject to volatility.
What is the AI Prediction for Biopol Chemicals SME?
Our AI algorithm currently rates this IPO as "NEUTRAL" with a score of 48.5/100. This analysis is based on data patterns and is for educational purposes only, not financial advice.
When will the allotment for Biopol Chemicals SME be announced?
The allotment status for Biopol Chemicals SME is expected to be finalized on 11 Feb 2026. Investors can check their status on the registrar's website.
What is the listing date for Biopol Chemicals SME?
Shares of Biopol Chemicals SME are proposed to be listed on stock exchanges on 13 Feb 2026.
Liability Disclaimer: Ipofly.com is an informational platform. We are not SEBI registered. The information provided here (including GMP and AI analysis) is for educational purposes only and should not be considered financial advice. Investments in the stock market are subject to market risks. Please consult your financial advisor before investing.